New EUS needle test could predict deadly liver bleeding

NCT ID NCT04633356

Recruiting now Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new method using an endoscope with ultrasound to measure pressure in the liver's blood vessels. It aims to see if this technique is safe and can predict complications like bleeding in 30 patients with cirrhosis from chronic hepatitis. The procedure is done during a routine upper endoscopy, making it more convenient for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EUS-portal pressure gradient measurement (PPGM) device
What this could lead to: If successful, this could provide a safer, easier way to measure portal pressure and predict complications in cirrhosis patients.
What could go wrong: This is an early-phase study with only 30 participants, so results may not apply broadly. The procedure carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS PORTAL HYPERTENSION

Contacts and locations

Locations

Chinese University of Hong Kong
RECRUITING

Hong Kong, Hong Kong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.